NovaBay Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBY and other ETFs, options, and stocks.About NBY
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor.
CEOMichael Kazley
CEOMichael Kazley
Employees14
Employees14
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2000
Founded2000
Employees14
Employees14
NBY Key Statistics
Market cap6.29M
Market cap6.29M
Price-Earnings ratio-0.57
Price-Earnings ratio-0.57
Dividend yield—
Dividend yield—
Average volume140.07K
Average volume140.07K
High today$1.08
High today$1.08
Low today$0.995
Low today$0.995
Open price$1.06
Open price$1.06
Volume162.47K
Volume162.47K
52 Week high$4.44
52 Week high$4.44
52 Week low$0.46
52 Week low$0.46
Stock Snapshot
As of today, NovaBay Pharmaceuticals(NBY) shares are valued at $1.04. The company's market cap stands at 6.29M, with a P/E ratio of -0.57.
During the trading session on 2025-11-07, NovaBay Pharmaceuticals(NBY) shares reached a daily high of $1.08 and a low of $1.00. At a current price of $1.04, the stock is +4.5% higher than the low and still -3.7% under the high.
Trading activity shows a volume of 162.47K, compared to an average daily volume of 140.07K.
Over the past 52 weeks, NovaBay Pharmaceuticals(NBY) stock has traded between a high of $4.44 and a low of $0.46.
Over the past 52 weeks, NovaBay Pharmaceuticals(NBY) stock has traded between a high of $4.44 and a low of $0.46.
People also own
Based on the portfolios of people who own NBY. This list is generated using Robinhood data, and it’s not a recommendation.